Journal article

BMS-986165, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor: Evaluation of Changes in Laboratory Parameters in Response to Treatment in a Phase 2 Trial in Psoriasis Patients

Kenneth Gordon, Kim Papp, Melinda Gooderham, Akimichi Morita, Peter Foley, Diamant Thaçi, Sundeep Kundu, Renata Kisa, Lan Wei, Subhashis Banergee

SKIN The Journal of Cutaneous Medicine | National Society for Cutaneous Medicine

DOI: 10.25251/skin.4.supp.28

Download PDF

Abstract

Abstract not available.

Citation metrics

3Dimensions